Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
ORGO logo

ORGO

NSC
Organogenesis Holdings Inc.
HealthcareDrug Manufacturers - Specialty & Generic
Watchlists:
Last updated: Sunday 20th July 2025
4.37
+0.01 (0.23%)
Prev Close:4.36
Open:4.45
Bid:4.34
Ask:4.5
52 Week Range
2.28
6.71
Volume:1,308,816
Mkt Cap:511 M
Price Target
$5.03
+15.1%

Financial Statements

ORGO - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Invalid date
Accretion On Preferred Stock412000.0
Accrued Preferred Stock Dividends937000.0-5 M645000.0
Acquisition Expense87 M
Depreciation And Amortization14 M10 M6 M6 M4 M3 M-3 M-4 M
Gain On Sale Of PPE-559000.0-1 M8000.0
General And Administrative Expense295 M270 M284 M250 M204 M200 M-5 M-4 M
Gross Profit Margin (profit Margin After CGS)366 M327 M346 M353 M251 M185 M125 M137 M91 M
Interest Expense Non Operating197000.0137000.02 M7 M11 M9 M11 M8 M
Loss And Loss Adjustment Expected Incurred76 M
Minority Interests-863000.0
Misc Other Special Charges20000.057000.0-13000.0-2 M2 M-2 M-2 M-9000.0
Net Income (loss)861000.05 M16 M94 M17 M-40 M-65 M-8 M-208698.0
Net Income Common Stockholders-937000.05 M16 M94 M17 M-41 M-65 M-8 M-208698.0
Net Income Continuous Operations861000.05 M16 M94 M17 M-40 M-65 M-8 M-208698.0
Net Income Discontinuous Operations1 M418000.0
Net Non Operating Interest Income Expense-197000.0-137000.02 M-7 M-11 M-9 M-11 M-9 M
Non Recurring Operation Expense-2 M
Normalized Income12 M
Operating Income-1 M13 M22 M72 M27 M-29 M-52 M-5 M-208698.0
Operating Income Before Depreciation (EBITDA)23 M34 M40 M87 M37 M-22 M-47 M-783000.0-15 M
Operating Expense368 M314 M324 M281 M224 M214 M-176 M-143 M-208698.0
Other Gand A295 M270 M284 M250 M204 M200 M-5 M-4 M
Other Impairment Of Capital Assets19 M
Other Operating Expenses20 M-113000.0-206000.0-153000.0-111000.06 M3 M-1 M208698.0
Otherunder Preferred Stock Dividend1 M-5 M645000.0
Preferred Stock Dividends1 M-5 M645000.0
Provision For Gain Loss On Disposal1 M418000.0
Rent And Landing Fees-2 M-2 M
Research Expense50 M44 M40 M145 M20 M15 M11 M9 M
Restructring And Mn A Income4 M2 M5 M-423000.0
Salaries And Wages76 M
Selling And Marketing Expense162 M134 M
Selling Expense162 M134 M
Total Income Available For Interest Expense (EBIT)-3 M11 M22 M70 M29 M-31 M-54 M-6 M-15 M
Total Revenues482 M433 M451 M467 M338 M261 M193 M199 M139 M
Total Expenses483 M421 M429 M395 M312 M290 M-245 M-204 M-48 M
Total Revenue482 M433 M451 M467 M338 M261 M193 M199 M139 M
Write Down87 M
Amord30 M29 M29 M30 M29 M26 M-4 M-2 M
Avgshs132 M131 M130 M128 M108 M93 M69 M64 M8 M
Avgshsdt132 M133 M132 M134 M111 M69 M64 M7 M
Basiceps-0.010.040.120.740.17-0.44-0.07
Basicepscont-0.010.040.120.740.17-0.44
Cor116 M106 M105 M114 M87 M76 M-69 M-61 M-48 M
Depamor14 M10 M6 M6 M4 M3 M-3 M-4 M
Dileps-0.010.040.120.710.16-0.44-0.94-0.14-0.03
Dilepscont-0.010.040.120.710.16
Intinc78000.0-469000.0-908000.0
Netincdisc861000.05 M16 M94 M17 M-40 M-65 M-8 M-208698.0
Othincexp19 M-57000.0-13000.02 M-2 M2 M2 M9000.0
Pretaxinc-3 M10 M20 M63 M18 M-40 M-65 M-15 M-15 M
Resdev50 M44 M40 M145 M20 M15 M11 M9 M
Restruct4 M2 M5 M-423000.0
Sga295 M270 M284 M250 M204 M200 M162 M134 M
Shsout127 M132 M131 M129 M128 M105 M92 M39 M39 M
Specincchg-4 M-2 M-5 M2 M423000.0
Taxprov-4 M5 M5 M-31 M530000.0150000.084000.0-7 M